Otrivin Complete nasal dosing spray

Active Ingredients

Each ml contains:

Ipratropium Bromide 0.6 mg/ml

Xylometazoline Hydrochloride 0.5 mg/ml

Indications

Therapeutic group:

Xylometazoline Hydrochloride - Sympathomimetics

Ipratropium Bromide - Anticholinergics

Therapeutic activity:

Otrivin Complete provides a dual treatment with 2 active ingredients: Xylometazoline HCL - acts to rapidly relieve nasal congestion after 5-10 minutes. Ipratropium Bromide - acts to reduce runny nose secretion (rhinorrhea) associated with common colds within 15 minutes.

Instructions

Do not swallow! This medicine is intended for external use only.

Always blow your nose before using the spray. Remove the protective cap before the first application and press the spray pump approximately 4 times into the air. Now it is ready for use. Hold the bottle upright. Tilt your head slightly forward , close one nostril by using your finger and insert the spray tip into the other nostril. Press the pump quickly while inhaling through the nose. The medicine's effect will be felt 5-15 minutes later. Repeat this procedure in the other nostril.

Rinse the tip of the bottle with warm water, taking care that water does not enter the bottle. Wipe with a clean paper tissue and close the bottle. To avoid spreading of infection, do not use the same bottle for more than one person.

Recommended dosage unless otherwise prescribed by your doctor:

Adults over 18 years of age:

One spray in each nostril , up to 3 times daily. Wait at least 6 hours between doses. Do not use this medicine for more than 7 days. Use for more than 7 days may cause the nasal mucosa to swell.

Do not exceed the recommended dose.

Refer to your doctor if the symptoms worsen or do not improve after 7 days.

It is recommended to stop the treatment when the symptoms of nasal congestion and runny nose have diminished, even if 7 days have not yet passed, in order to decrease the chance of occurrence of side effects.

Warnings

Do not use this medicine if you are sensitive to any of its ingredients , atropine or similar substances , e.g. scopolamine.

Do not use this medicine in children and adolescents under 18 years of age and in patients over 70 years of age since there is not enough experience in this patient group.

Do not use this medicine after a surgery in which the pituitary gland (hypophysis) has been removed through the nose or after nose and pharynx surgeries in which the meninges were damaged.

Do not use this medicine if you suffer from glaucoma.

Do not use this medicine if you suffer from rhinitis sicca (nasal congestion characterized by dryness).

Avoid spraying Otrivin Complete in or around the eye. If Otrivin Complete comes in contact with the eye, you may experience temporary blurred vision , irritation of the eye , redness or pain in the eye. Worsening of narrow angle glaucoma may also occur. In case Otrivin Complete comes in contact with the eye, rinse the eye with water and contact your doctor if your eyes are sore or your vision is blurred.

Do not use this medicine without consulting a doctor before starting treatment:

• If you are pregnant or breastfeeding
• If you are sensitive to adrenergic substances e.g. adrenaline, ephedrine
• If you suffer from a cardiovascular disease, hypertension, diabetes or increased activity of the thyroid gland (hyperthyroidism)
• In case of enlargement of the prostate, narrowing of the urethra, narrow angle glaucoma
• If you suffer from nosebleeds
• If you suffer from intestinal obstruction or from cystic fibrosis
• If you suffer from a benign tumor of the pheochromocytoma type, which causes increased production of adrenaline and noradrenaline

If you are taking another drug concomitantly, including non prescription drugs and food supplements, or if you have just finished treatment with another medicine, inform the attending doctor, in order to prevent hazards or lack of efficacy arising from drug interactions.

This is especially important for medicines belonging to the following groups: antidepressants: monoamine oxidase inhibitors (MAOIs) or antidepressants from the tricyclic and tetracyclic group. Do not use these medicines for at least two weeks after cessation of treatment with Otrivin Complete.

Please do not consider this information as an alternative to consulting your physician or pharmacist.

For further information on instructions for use, risks and side effects, please read the patient package insert and consult your doctor or pharmacist.
Read the patient package insert carefully before starting to take any medication.